Drug Profile
Research programme: vanilloid prodrugs - Malachite Innovations
Latest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator Vitality Biopharma
- Developer Malachite Innovations
- Class Analgesics
- Mechanism of Action TRPV1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Pain in USA
- 05 Apr 2017 Vitality Biopharma files for International patent protection for vanilloid prodrugs
- 09 Nov 2016 Vitality files for patent protection with The Patent Cooperation Treaty (PCT) for vanniloid prodrugs